Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,457 | 3,658 | 3,864 | 2,129 | N/A |
| Income taxes - deferred | 23 | 160 | -372 | 782 | N/A |
| Accounts receivable | -5,042 | 618 | -1,097 | 1,715 | N/A |
| Other Working Capital | 1,581 | -1,733 | -1,912 | 1,782 | 69 |
| Other Operating Activity | 13,481 | -215 | 4,436 | 604 | 2,909 |
| Operating Cash Flow | $12,500 | $2,488 | $4,918 | $7,013 | $2,978 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,241 | -1,504 | -1,615 | -1,366 | -1,159 |
| Net Acquisitions | N/A | -312 | -22,264 | N/A | N/A |
| Sale Of Investment | N/A | 508 | 299 | 629 | 1,119 |
| Other Investing Activity | 0 | -104 | -96 | -734 | 195 |
| Investing Cash Flow | $-3,241 | $-1,412 | $-23,675 | $-1,470 | $156 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,877 | N/A | 596 | 295 | 13,719 |
| Dividend Paid | N/A | N/A | -3,065 | -3,349 | -4,257 |
| Other Financing Activity | -2,964 | -3,276 | 10,535 | -3,221 | -3,477 |
| Financing Cash Flow | $-1,087 | $-3,276 | $8,066 | $-6,275 | $5,985 |
| Exchange Rate Effect | -198 | -241 | -399 | N/A | N/A |
| Beginning Cash Position | 857 | 3,268 | 14,120 | 12,363 | 3,107 |
| End Cash Position | 8,832 | 828 | 3,030 | 11,631 | 12,226 |
| Net Cash Flow | $8,173 | $-2,199 | $-10,691 | $-732 | $9,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,500 | 2,488 | 4,918 | 7,013 | 2,978 |
| Capital Expenditure | -5,412 | -1,504 | -1,646 | -2,009 | -1,192 |
| Free Cash Flow | 7,088 | 984 | 3,272 | 5,004 | 1,786 |